Alnylam Pharmaceuticals
ALNY
#452
Rank
$51.90 B
Marketcap
$392.92
Share price
-4.78%
Change (1 day)
54.60%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company